[1]黄盼盼,陈国荣.家族聚集性肺癌一家系报告[J].新乡医学院学报,2021,38(4):349-352.[doi:10.7683/xxyxyxb.2021.04.011]
　HUANG Panpan,CHEN Guorong.Familial cluster lung cancer family report[J].Journal of Xinxiang Medical University,2021,38(4):349-352.[doi:10.7683/xxyxyxb.2021.04.011]
点击复制

家族聚集性肺癌一家系报告
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年4
页码:
349-352
栏目:
临床研究
出版日期:
2021-04-05

文章信息/Info

Title:
Familial cluster lung cancer family report
作者:
黄盼盼1; 陈国荣2
（1.新乡医学院第三临床学院，河南　新乡　453003；2.新乡医学院第三附属医院肿瘤内科，河南　新乡　453003）
Author(s):
HUANG Panpan1; CHEN Guorong2
(1.The Third Clinical College of Xinxiang Medical University,Xinxiang 453003,Henan Province,China2.Department of Oncology,the Third Affiliated Hospital of Xinxiang Medical University,Xinxiang 453003,Henan Province,China)
关键词:
家族聚集; 肺癌; 白细胞介素-6; 血管内皮生长因子; C-反应蛋白
Keywords:
family gatheringlung cancerinterleukin-6vascular endothelial growth factorC-reactive protein
分类号:
R734.2
DOI:
10.7683/xxyxyxb.2021.04.011
文献标志码:
A
摘要:
目的　探讨肺癌的发生与机体血清中白细胞介素-6（IL-6）、血管内皮生长因子（VEGF）、C-反应蛋白（CRP）水平的关系。方法　分析2015年10月就诊于新乡医学院第三附属医院肿瘤内科的1例肺癌患者（先证者）所在家系3代成员中肺癌发病情况，并根据是否患肺癌将家系成员分为观察组（n=4）和对照组(n=14)。 检测2组研究对象血清中IL-6、VEGF、CRP水平并进行比较。结果　先证者所在家系（3代）共18位成员，其中4位患肺癌，其余14位成员未发现有肺癌征象。观察组患者血清中IL-6、VEGF、CRP水平显著高于对照组（P<0.05）。>结论　对于有肺癌家族史的成员来说，早期检测血清IL-6、VEGF、CRP表达水平，对于及时发现肺癌征象可能具有一定的临床意义。undefined
Abstract:
Objective　To explore the relationship between the serum levels of interleukin-6 (IL-6),vascular endothelial growth factor (VEGF),C-reactive protein (CRP) and lung cancer.Methods　　The incidence of lung cancer in 3 generations of a proband′s family admitted to Department of Oncology,the Third Affiliated Hospital of Xinxiang Medical University on October 2015 was analyzed,and the family members were divided into observation group (n=4) and control group (n=14) according to whether they had lung cancer.The serum levels of IL-6,VEGF and CRP of subjects in the two groups were determined and compared.Results　Among the 18 members of the proband′s family (3 generations),4 members had lung cancer,and the other 14 members had no signs of lung cancer.The serum levels of IL-6,VEGF and CRP of the subjects in the observation group were significantly higher than those in the control group (P<0.05).Conclusion　For members with family history of lung cancer,early detection of the levels of IL-6,VEGF and CRP in serum may have a certain significance for timely detection of lung cancer signs.

参考文献/References:

［1］　SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2016［J］.CA Cancer J Clin,2016,66(1):7-30.
［2］　YUCEL S,BILGIN B.The prognostic values of systemic immu-neinflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer［J］.J Oncol Pharm Pract，2021，27(1):71-77.
［3］　MOHAN A,HARRIS K,BOWLING M R,et al.Therapeutic bronchoscopy in the era of genotype directed lung cancer management［J］.J Thorac Dis,2018,10(11):6298-6309.
［4］　MOHAN A,LATIFI A N,GULERIA R.Increasing incidence of adenocarcinoma lung in India:following the global trend［J］.Indian J Cancer,2016,53(1):92-95.
［5］　RAO S A,KUNTE A R.Interleukin-6:an early predictive marker for severity of acute pancreatitis［J］.Indian J Crit Care Med,2017,21(7):424-428.
［6］　刘涓,孙威.IL-6和IGF-1在非小细胞肺癌组织的表达与临床意义［J］.中国组织化学与细胞化学杂志,2015,24(5):399-403.
［7］　CAETANO M S,ZHANG H,CUMPIAN A M,et al.IL-6 blockade reprograms the lung tumor microenvironment to limit the development and progression of K-ras-mutant lung cancer［J］.Cancer Res,2016,76(11):3189-3199.
［8］　李林,杨智晖,刘青,等.血清IL-6、IL-8、TNF-α在COPD患者肺癌辅助诊断中的价值分析［J］.川北医学院学报,2019,34(3):344-348.
［9］　ZHAO Y,ADJEI A A.Targeting angiogenesis in cancer therapy:moving beyond vascular endothelial growth factor［J］.Oncologist,2015,20(6):660-673.
［10］　陈坚,王棣,向小俐,等.血清TK1、CD147、VEGF、CYFRA21-1和CEA联合检测对非小细胞肺癌的诊断价值研究［J］.标记免疫分析与临床,2019,26(7):1135-1140.
［11］　OKUGAWA Y,TOIYAMA Y,YAMAMOTO A,et al.Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer［J］.Ann Surg,2020,272(2):342-351.
［12］　TOMITA M,AYABE T,MAEDA R,et al.Combination of advanced lung cancer inflammation index and C-reactive protein is a prognostic factor in patients with operable non-small cell lung cancer［J］.World J Oncol,2017,8(6):175-179.
［13］　JING X,HUANG C,ZHOU H,et al.Association between serum C-reactive protein value and prognosis of patients with non-small cell lung cancer:a meta-analysis［J］.Int J Clin Exp Med,2015,8(7):10633-10639.
［14］　FIALA O,PESEK M,FINEK J,et al.High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib［J］.Tumour Biol,2015,36(12):9215-9222.
［15］　李洁.C反应蛋白联合肿瘤标志物在肺癌诊断中的应用价值［J］.临床医学研究与实践,2018,3(6):4-5,8.

相似文献/References:

[1]杜华贞,和瑞芝,千高峰,等.肺癌痰液脱落细胞学检查——附164例分析[J].新乡医学院学报,1988,5(02):022.
[2]张彩平,范迎胜,李 新,等.肺癌患者医院真菌感染原因调查分析[J].新乡医学院学报,2002,19(05):416.
[3]朱自德.青年肺癌1O例临床分析[J].新乡医学院学报,2003,20(03):213.
[4]朱自德.青年肺癌10例临床分析[J].新乡医学院学报,2003,20(03):213.
[5]房秀清,尹丽欣,钞丽红.胸腔积液中癌胚抗原及CA125 和CA153 联合检测对肺癌的诊断意义[J].新乡医学院学报,2012,29(06):428.
[6]牛慧彦,王鑫,张萌,等.雷帕霉素联合多西紫杉醇对肺癌细胞增殖和凋亡的影响[J].新乡医学院学报,2012,29(01):000.
[7]孙 冰,杨亚勤,韩 伟,等.自发荧光支气管镜在肺癌早期诊断中的应用[J].新乡医学院学报,2013,30(03):223.
[8]郭煜颍,张　敏,刘彦廷,等.小分子酪氨酸激酶抑制剂安罗替尼在肺癌治疗中的应用研究进展[J].新乡医学院学报,2021,38(10):986.[doi:10.7683/xxyxyxb.2021.10.018]
[9]屈亚云,武莉芳,张秀敏,等.依达拉奉对肺癌胸腔镜手术中单肺通气相关肺损伤的保护作用[J].新乡医学院学报,2016,33(12):1054.[doi:10.7683/xxyxyxb.2016.12.010]
　QU Ya-yun,WU Li-fang,ZHANG Xiu-min,et al.Protective effect of edaravone on injury of lungs induced by one lung ventilation in lung cancer patients undergoing thorascopic surgery[J].Journal of Xinxiang Medical University,2016,33(4):1054.[doi:10.7683/xxyxyxb.2016.12.010]
[10]周　威,陈贡斌,刘海燕,等.黄芪甲苷对乌拉坦诱导肺癌小鼠的防治作用及其机制[J].新乡医学院学报,2021,38(1):018.[doi:10.7683/xxyxyxb.2021.01.004]
　ZHOU Wei,CHEN Gongbin,LIU Haiyan,et al.Preventive and therapeutic effects of astragaloside IV on urethane induced lung cancer in mice and its mechanism[J].Journal of Xinxiang Medical University,2021,38(4):018.[doi:10.7683/xxyxyxb.2021.01.004]

更新日期/Last Update: 2021-04-05